“…Our motivation to develop a 5Ј NCR assay was largely due to our interest in having a protocol to allow broad and sensitive detection and typing of HRVs for molecular epidemiology and surveillance. Detection and typing of HRVs can shed light on the contribution of specific serotypes of HRVs to more severe clinical outcomes associated with HRV infection, including asthma exacerbation (6,14,15) and lower respiratory infections (3,5), some of which have had fatal outcomes (4,8,12,17). The discovery of novel strains that coincide with the novel HRV A2/"C" strains (1, 10, 13) as well as a potential novel genogroup of HRV (7,11), which we will refer to in this article as HRV "D" to distinguish it from the currently proposed HRV "C", was a fortuitous and exciting finding from the evaluation of our novel assay on field isolates.…”